Protected: The VESL Wall Issue #8 is now out! In this issue, we feature an analysis of LDLR genotypes and lipid-lowering therapy, the association between different hypertensives and the risk of new onset diabetes, and hear a definitive call to elevate apoB measurements in routine clinical care.

This content is password protected. To view it please enter your password below: